Of interest, morphine-induced attenuation of breast cancer cell growth involved a rearrangement of the ErbB signaling network suggesting that morphine provides a promising strategy to enhance the sensitivity of breast cancer cells to ErbB-directed therapies [67]. Here, EGFR is linked to breast carcinoma.